E
EddieM
Not sure I understand the logic here. OK Germanies premise is that there is insufficient data to verify efficacy in over 65's.
I believe in the AZ clinical trials only 8% that were over 65? Not that the vaccine had 8% efficacy in over 65s as was reported in Germany.
So, ok I get that. But Germany like many countries has a shortage of vaccines.
So for over 65s are they planning on only giving the pfizer vaccine, also in short supply, or not vaccinating them at all?
Someone might know the answer.
I believe in the AZ clinical trials only 8% that were over 65? Not that the vaccine had 8% efficacy in over 65s as was reported in Germany.
So, ok I get that. But Germany like many countries has a shortage of vaccines.
So for over 65s are they planning on only giving the pfizer vaccine, also in short supply, or not vaccinating them at all?
Someone might know the answer.